BIOMAT Database Logo BIOMAT Database Logo

Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients. 1989

M A Jenike, and L Baer, and P Summergrad, and J B Weilburg, and A Holland, and R Seymour
Harvard Medical School and Massachusetts General Hospital, Boston 02114.

Clomipramine was significantly superior to placebo in a 10-week double-blind, placebo-controlled trial in 27 outpatients who met DSM-III-R criteria for obsessive-compulsive disorder.

UI MeSH Term Description Entries
D008297 Male Males
D009771 Obsessive-Compulsive Disorder An anxiety disorder characterized by recurrent, persistent obsessions or compulsions. Obsessions are the intrusive ideas, thoughts, or images that are experienced as senseless or repugnant. Compulsions are repetitive and seemingly purposeful behavior which the individual generally recognizes as senseless and from which the individual does not derive pleasure although it may provide a release from tension. Anankastic Personality,Neurosis, Obsessive-Compulsive,Anankastic Personalities,Disorder, Obsessive-Compulsive,Disorders, Obsessive-Compulsive,Neuroses, Obsessive-Compulsive,Neurosis, Obsessive Compulsive,Obsessive Compulsive Disorder,Obsessive-Compulsive Disorders,Obsessive-Compulsive Neuroses,Obsessive-Compulsive Neurosis,Personalities, Anankastic,Personality, Anankastic
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D002997 Clomipramine A tricyclic antidepressant similar to IMIPRAMINE that selectively inhibits the uptake of serotonin in the brain. It is readily absorbed from the gastrointestinal tract and demethylated in the liver to form its primary active metabolite, desmethylclomipramine. Chlorimipramine,Anafranil,Chlomipramine,Clomipramine Hydrochloride,Clomipramine Maleate (1:1),Clomipramine Monohydrochloride,Hydiphen,Hydrochloride, Clomipramine,Monohydrochloride, Clomipramine
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M A Jenike, and L Baer, and P Summergrad, and J B Weilburg, and A Holland, and R Seymour
Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients.
July 1990, The Journal of clinical psychiatry,
M A Jenike, and L Baer, and P Summergrad, and J B Weilburg, and A Holland, and R Seymour
Combination of clomipramine and nortriptyline in the treatment of obsessive-compulsive disorder: a double-blind, placebo-controlled trial.
April 1998, Journal of clinical pharmacy and therapeutics,
M A Jenike, and L Baer, and P Summergrad, and J B Weilburg, and A Holland, and R Seymour
A double-blind, placebo-controlled trial of clonazepam in obsessive-compulsive disorder.
January 2003, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry,
M A Jenike, and L Baer, and P Summergrad, and J B Weilburg, and A Holland, and R Seymour
Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline.
June 1983, Archives of general psychiatry,
M A Jenike, and L Baer, and P Summergrad, and J B Weilburg, and A Holland, and R Seymour
Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study.
October 1985, Archives of general psychiatry,
M A Jenike, and L Baer, and P Summergrad, and J B Weilburg, and A Holland, and R Seymour
Tolcapone in obsessive-compulsive disorder: a randomized double-blind placebo-controlled crossover trial.
September 2021, International clinical psychopharmacology,
M A Jenike, and L Baer, and P Summergrad, and J B Weilburg, and A Holland, and R Seymour
A double-blind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder.
December 2011, Journal of clinical psychopharmacology,
M A Jenike, and L Baer, and P Summergrad, and J B Weilburg, and A Holland, and R Seymour
Topiramate augmentation in refractory obsessive-compulsive disorder: A randomized, double-blind, placebo-controlled trial.
October 2014, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences,
M A Jenike, and L Baer, and P Summergrad, and J B Weilburg, and A Holland, and R Seymour
Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial.
May 2000, European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,
M A Jenike, and L Baer, and P Summergrad, and J B Weilburg, and A Holland, and R Seymour
Treatment of obsessive-compulsive disorder with fluvoxamine: a multicentre, double-blind, placebo-controlled trial.
March 1996, International clinical psychopharmacology,
Copied contents to your clipboard!